National Center for Antimicrobials and Infection Control, Statens Serum Institut, Copenhagen, Denmark.
Clin Microbiol Infect. 2010 Sep;16(9):1427-34. doi: 10.1111/j.1469-0691.2009.03137.x.
In the aftermath of a methicillin-resistant Staphylococcus aureus (MRSA) ST22 hospital outbreak, we investigated the prevalence of long-term carriage, the efficacy of MRSA decolonization treatment (DT) and the spread of MRSA to households of patients and healthcare workers (HCWs). Furthermore, we evaluated the efficacy of repeated DT in long-term MRSA carriers. Of 250 index persons (58 HCWs and 192 patients), 102 persons (19 HCWs and 83 patients) and 67 household members agreed to participate. Samples from all 169 persons were taken from the nose, throat, wounds and devices/catheters, and urine samples were additionally taken from index persons. Samples from companion animals (n = 35) were taken from the nostrils and anus. Environmental sites (n = 490) screened were telephone, television remote control, toilet flush handle, favourite chair and skirting board beside the bed. Sixteen (19%) patients and two household members, but no HCWs, were ST22-positive. The throat was the most frequent site of colonization. In a multivariate analysis, chronic disease (p <0.001) and pharyngeal carriage (p <0.001) were associated with long-term MRSA carriage. MRSA was found in the environments of four long-term carriers. All animals tested were negative. MRSA-positive households were decolonized using nasal mupirocin TID and daily chlorhexidine body and hair wash for 5 days. Pharyngeal MRSA carriers also received fucidic acid (500 mg TID) combined with rifampicin (600 mg BID) or clindamycin (600 mg BID) for 7 days. The home environment was cleaned on days 2 and 5. At the end of follow-up, ten of 16 long-term carriers and the two household contacts were MRSA-negative. In conclusion, decolonization of MRSA carriers is possible, but should include treatment of household members and the environment.
在耐甲氧西林金黄色葡萄球菌(MRSA)ST22 医院爆发后,我们调查了长期携带的流行率、MRSA 去定植治疗(DT)的疗效以及 MRSA 传播到患者和医护人员(HCWs)家庭的情况。此外,我们评估了重复 DT 在长期 MRSA 携带者中的疗效。在 250 名索引个体(58 名 HCWs 和 192 名患者)中,102 名个体(19 名 HCWs 和 83 名患者)和 67 名家庭成员同意参与。从所有 169 名个体的鼻子、喉咙、伤口和器械/导管中采集样本,并从索引个体中采集尿液样本。从伴侣动物(n=35)中采集鼻和肛门样本。共筛查了 490 个环境部位(电话、电视遥控器、马桶冲水手柄、最喜爱的椅子和床边踢脚板)。16 名(19%)患者和 2 名家庭成员,但无 HCWs 为 ST22 阳性。喉咙是最常见的定植部位。在多变量分析中,慢性疾病(p<0.001)和咽部定植(p<0.001)与长期 MRSA 携带有关。在 4 名长期携带者的环境中发现了 MRSA。所有检测的动物均为阴性。使用鼻莫匹罗星 TID 和每天氯己定身体和头发清洗 5 天对 MRSA 阳性家庭进行去定植。咽部 MRSA 携带者还接受了夫西地酸(500mg TID)联合利福平(600mg BID)或克林霉素(600mg BID)治疗 7 天。在第 2 天和第 5 天清洁家庭环境。在随访结束时,16 名长期携带者中的 10 名和 2 名家庭接触者的 MRSA 检测结果为阴性。总之,MRSA 携带者的去定植是可能的,但应包括家庭成员和环境的治疗。